Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.18Asset Turnover
VS
Market
Sector
Industry
History
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - Asset Turnover Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - Asset Turnover Historical data
| Date | Total Assets | Asset Turnover | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 426.04M | 0.18 | $ 77.2M |
| 3/31/2025 | $ 343.58M | 0.19 | $ 65.27M |
| 12/31/2024 | $ 354.16M | 0.18 | $ 64.38M |
| 9/30/2024 | $ 356.11M | 0.18 | $ 63.19M |
| 6/30/2024 | $ 362.03M | 0.17 | $ 62.02M |
| 3/31/2024 | $ 371.31M | 0.17 | $ 61.51M |
| 12/31/2023 | $ 382M | 0.15 | $ 57.42M |
| 9/30/2023 | $ 413.59M | 0.13 | $ 54.51M |
| 6/30/2023 | $ 446.63M | 0.11 | $ 51.27M |
| 3/31/2023 | $ 538.55M | 0.09 | $ 48.57M |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) Asset Turnover stands at 0.16.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average Asset Turnover has been 0.15.
- The median Asset Turnover for THERAVANCE BIOPHARMA INC during this period was 0.15
- THERAVANCE BIOPHARMA INC reached its highest Asset Turnover over the past 5 years at 0.19.
- The lowest Asset Turnover recorded by THERAVANCE BIOPHARMA INC in the same timeframe 0.07
THERAVANCE BIOPHARMA INC's Asset Turnover vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Asset Turnover Benchmarks
Similar metrics to Revenues:
- Gross Profits to Assets - [Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
Definition of Asset Turnover
[Calculation] The Asset Turnover ratio measures how effective a company uses its assets to generate revenue. It is calculated as [Revenue] divided by [Assets].Revenues / Assets
(=) Asset Turnover Asset Turnover for THERAVANCE BIOPHARMA INC is calculated as follows: Revenues [ $ 82.63M ] / Assets [ $ 512.19M ]
(=) Asset Turnover [ 0.16 ] TBPH - Asset Turnover, Last 5 years
0.07
Minimum
Sep 30, 2022
0.19
Maximum
Mar 31, 2025
0.15
Average
0.15
Median
Asset Turnover Benchmark AnalysisMarket
The chart above depicts the distribution of Asset Turnover for companies in the Total Stock Market. The average Asset Turnover of the companies is 0.53 with a standard deviation of 0.52.
The following table provides additional summary stats:
Asset Turnover in the Market:
| filtered constituents | 4.17K |
|---|---|
| min | -0.79 |
| max | 2.36 |
| average | 0.53 |
| median | 0.4 |
| std | 0.52 |